Corient Private Wealth
NUVL

Corient Private Wealth’s Nuvalent NUVL Stock Holding History

Corient Private Wealth’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.15M Buy
+11,234
New +$1.14M ﹤0.01% 1579

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Corient Private Wealth's NUVL Position: Q1 2026 in Review

Corient Private Wealth opened a new position in Nuvalent (NUVL) in Q1 2026: 11,234 shares worth $1.15M. The stake represents ﹤0.01% of the portfolio and ranks #1579 among its holdings.

263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Corient Private Wealth held 11,234 shares of Nuvalent worth $1.15M as of Q1 2026.
  • Nuvalent was a new Corient Private Wealth position in Q1 2026.
  • Nuvalent made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #1579 holding.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.